MedPath

SANDOZ GLICLAZIDE

SANDOZ GLICLAZIDE

Discontinued
DIN Number

02254719

Drug Class

Human

Market Date

Aug 9, 2004

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02254719
AIG Number0119934001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BB09 GLICLAZIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

GLICLAZIDEActive
Strength: 80 MG
Monograph: GLICLAZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.